Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.
|Articles|December 9, 2010
Mineral Chelates for the Hypoallergenic Community
Albion Human Nutrition (Saint Clair Shores, MI) has received its latest patent, this one related to the composition, preparation, administration, and formulation of hypoallergenic metal amino acid chelates and the products containing them.
Advertisement
Albion Human Nutrition (Saint Clair Shores, MI) has received its latest patent, this one related to the composition, preparation, administration, and formulation of hypoallergenic metal amino acid chelates and the products containing them.
The company says that this patent addresses an increasing incidence of food and chemical sensitivities and allergies-a growing worldwide health problem that also now affects more than 50% of Americans. Food and chemical sensitivities can lead to physical problems such as arthritis to skin diseases and severe digestive disorders, the company adds.
The new patent (U.S. Patent #7,838,042) is titled “Hypoallergenic Metal Amino Acid Chelates and Metal Amino Acid Chelate Containing Compositions.”
Advertisement
Related to this article
A new Walmart-exclusive supplement from Lemme joins a fast-growing, category of products marketed around the body's natural GLP-1 production.
BENEO's Denisse Colindres discusses how the fibermaxxing trend is evolving beyond "more fiber" to fiber diversity and layering, and what that shift means for formulation, claims, and category opportunity.
Women are the predominant users of these drugs, and the authors say guidance has not kept pace, with nutrient gaps and supplement support also in focus.
From targeted benefits to new delivery formats, a roundup of recent beauty-from-within research, formats, and product launches.
TriNutra is presenting new data on its standardized black seed oil ingredient at SupplySide Global, adding to a growing body of research on how gut bacteria and the body's stress response may influence each other.
As GLP-1 medications and social media reshape how patients hear about nutrition, closing the gap between emerging science and everyday clinical care depends on stronger, more practical continuing education for healthcare providers.
A randomized crossover trial finds that formulation, not just dose, determines how much of the hops-derived compound xanthohumol actually reaches the bloodstream.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
New Research on Black Seed Oil Examines the Link Between Gut Bacteria and the Stress Response
2
Lemme's New "GLP-1 Production Support" Capsule Puts a Familiar Formulation Question to the Test
3
Lancet Review Flags Lean Mass Loss, Access Barriers for Women on GLP-1s
4
Skin Care Supplements: 2026 Trends for Manufacturers
5